hat
Yon etid ki pa blese, ki pa rannomize konpare oral desogestrel poud 75 mcg pou kont li chak jou (n = 42) nan yon aparèy entrarenè (n = 40) kòmanse 28 jou 56 apre akouchman pou kontrasepsyon. Pandan peryòd esè 7-mwa a, fanm lan te tonbe soti nan jijman an paske yo te laktasyon diminye konpare ak okenn nan gwoup la IUD. Nan fen sik tretman an premye ak katriyèm, pa te gen okenn diferans nan kantite lajan lèt ki te pwodwi ant poud desogestrel la ak gwoup IUD. Pa gen diferans ki genyen nan trigliserid, pwoteyin oswa kontni lèt nan lèt yo te jwenn nan fen 1, 1, ak 4 sik terapi.
eng
A nonblinded, nonrandomized study compared oral desogestrel powder 75 mcg alone daily (n = 42) to an intrauterine device (n = 40) begun 28 to 56 days postpartum for contraception. During the 7-month trial period, 1 woman dropped out of the trial because of diminished lactation compared with none in the IUD group. At the end of the first and fourth treatment cycle, there were no differences in the amount of milk produced between the desogestrel powder and IUD groups. No differences in triglyceride, protein or lactose content of milk were found at the end of 1, 4, and 7 cycles of therapy.